The changes of the immune system humoral link in the patients with nonalcoholic fatty leaver dease in combination with the obesity and concomitant pathology of biliary tract by Filippova, A.Yu.
ДЗ «Дніпропетровська медична академія МОЗ України»
ГО «Придніпровська асоціація лікарів інтерністів»
Департамент охорони здоров’я 
Дніпропетровської обласної державної адміністрації
АКТУАЛЬНІ ПИТАННЯ  
ВНУТРІШНЬОЇ МЕДИЦИНИ.
ВІД КЛІНІЧНИХ ДОСЛІДЖЕНЬ 
ДО КЛІНІЧНОЇ ПРАКТИКИ
тези наукових доповідей
науково-практичної конференції 
присвяченої 
пам’яті академіка НАМН України Г.В. Дзяка
   17–18 травня 2017 р. 
    м. Дніпро
Дніпро
«Герда» | 2017
30  | Актуальні питання внутрішньої медицини
Results. The five-year risk of development of proteinuria was 35,6 %. The most 
statistically reliable predictors of development of proteinuria in SSc patients in five 
years are shown in the table below.
Predictor Hazard ratio Confidence interval p
Age>43,7 years 0,56 0,21–1,51 0,25
Pulmonary 
fibrosis
2,33 0,85–6,44 0,10
Anemia 0,40 0,13-1.25 0,11
CRP>5 mg/l 0,39 0,13-1,18 0,10
RF>14 IU/ml 2,29 0,73–7,20 0,16
Influence of indicators of inflammatory activity (CRP, RF) was contradictory. 
None of the predictors has reached the critical value of p<0,05.
Conclusions. The five-year risk of development of proteinuria was 35,6 %. 
The strongest predictors of development of proteinuria were pulmonary fibrosis, 
CRP>5 mg/l and RF>14 IU/ml. Further investigation on larger sample is needed.
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The study of the humoral component of the immune system in patients at 
different stages of non-alcoholic fatty liver disease (NAFLD) has not been conducted 
and the mechanisms responsible for the development and progression of NAFLD with 
concomitant obesity (OB) and biliary tract (BT) pathology are not fully understood. 
There is a need in more detailed study of changes in the humoral immune system 
caused by immunoregulatory disorders and concomitant NAFLD to improve the 
efficiency of diagnosing the disease.
The objective of the research was to study the features of the indicators of 
the humoral component of the immune system depending on the body mass index 
in patients with non-alcoholic hepatic steatosis, non-alcoholic steatohepatitis, 
concomitant OB and BT pathology.
Material and methods. 200 patients with NAFLD, concomitant OB and BT 
pathology including 100 patients with non-alcoholic hepatic steatosis and 100 with 
non-alcoholic steatohepatitis were examined. 70 out of 100 patients with non-alcoholic 
steatohepatitis had the minimum level of alanine transaminase activity and 30 
patients had a moderate alanine transaminase activity. The control group included 30 
apparently healthy persons. The body mass index was determined using the Quetelet 
formula. All the patients with non-alcoholic hepatic steatosis and non-alcoholic 
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steatohepatitis were divided into three groups depending on the increase in the body 
mass index and the presence of biliary tract pathology. The humoral immune system 
state was evaluated by the levels of immunoglobulins A, M and G and the content of 
circulating immune complexes.
Results. In patients with non-alcoholic hepatic steatosis and non-alcoholic 
steatohepatitis, concomitant obesity and biliary tract pathology, there were observed 
abnormalities in the humoral component of the immune system with possible 
increase in the levels of major immunoglobulin classes as well as in the content of 
circulating immune complexes being more pronounced in patients with non-alcoholic 
steatohepatitis compared to patients with non-alcoholic hepatic steatosis (p<0,05) 
and apparently healthy persons (p<0,001). The increase in the body mass index led 
to a significant increase in the levels of Ig A, M, G and the activation of circulating 
immune complexes.More significant changes in humoral indices were observed in 
patients with chronic non-calculous and calculous cholecystitis in the presence of 
inflammatory BT changes during the exacerbation of the pathology compared to 
patients who underwent cholecystectomy on the background of the aggravation of 
postcholecystectomy syndrome.
Conclusions. The obtained data indicated that one of the elements in the 
pathogenesis of non-alcoholic fatty liver disease with concomitant OB and BT 
pathology is a significant change in the indicators of humoral immunity, namely the 
increase in the levels of Ig (A, M, G) and circulating immune complexes which depend 
on the clinical form (non-alcoholic hepatic steatosis or non-alcoholic steatohepatitis), 
increase in the body mass index and the presence of BT comorbidity.
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Aortic valve stenosis (AS) is the most common form of valvular heart disease 
in the elderly population and frequently occurs in conjunction with coronary 
artery disease and chronic heart failure (CHF). Meldonium had shown myocardial 
cytoprotection effect, however the role of meldonium in the elderly pts with CHF and 
AS disease remains debatable. 
Objectives: we aimed to evaluate the effects of meldonium in elderly patients 
with CHF with preserved ejection fraction and AS. 
Methods: 51 pts (31 M, 20 F, mean age – 74,97±2,75 years) with CHF NYHA 
I–III class and AS were enrolled. 26 (51 %) pts received the standard treatment 
and meldonium 500 mg/day (1 group), while 25 (49 %) (2 group) – received only the 
standard treatment for 12 weeks. Echocardiographic parameters, 6 min walk test 
were performed in all pts at baseline and at the end of the study. Aortic valve area 
(AVA) was calculated by Doppler echocardiography in all pts. 
